Witnessing the stock’s movement on the chart, on Wednesday, Roivant Sciences Ltd (NASDAQ: ROIV) set off with pace as it heaved 2.97% to $11.44, before settling in for the price of $11.11 at the close. Taking a more long-term approach, ROIV posted a 52-week range of $8.73-$13.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its Annual Earning per share during the time was -99.51%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -397.62%. This publicly-traded company’s shares outstanding now amounts to $695.94 million, simultaneously with a float of $418.04 million. The organization now has a market capitalization sitting at $7.78 billion. At the time of writing, stock’s 50-day Moving Average stood at $10.86, while the 200-day Moving Average is $11.24.
Roivant Sciences Ltd (ROIV) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Roivant Sciences Ltd’s current insider ownership accounts for 38.51%, in contrast to 71.21% institutional ownership. Preceding that transaction, on Jun 04 ’25, Company’s 10% Owner sold 547,430 for 11.34, making the whole transaction’s value amount to 6,207,856. This particular insider is now the holder of 38,627,181 in total.
Roivant Sciences Ltd (ROIV) Earnings and Revenue Records
Roivant Sciences Ltd’s EPS decrease for this current 12-month fiscal period is -397.62% and is forecasted to reach -1.33 in the upcoming year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Let’s observe the current performance indicators for Roivant Sciences Ltd (ROIV). It’s Quick Ratio in the last reported quarter now stands at 33.47. The Stock has managed to achieve an average true range (ATR) of 0.36. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 102.07.
In the same vein, ROIV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.25, a figure that is expected to reach -0.25 in the next quarter, and analysts are predicting that it will be -1.33 at the market close of one year from today.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Going through the that latest performance of [Roivant Sciences Ltd, ROIV]. Its last 5-days volume of 6.02 million indicated improvement to the volume of 5.74 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 39.31% While, its Average True Range was 0.37.
Raw Stochastic average of Roivant Sciences Ltd (ROIV) in the period of the previous 100 days is set at 88.71%, which indicates a major rise in contrast to 62.09% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 26.07% that was lower than 34.52% volatility it exhibited in the past 100-days period.
